Summary of Key Points
Macau previously reported that the “Royal Nestle Milk Powder 1” contained excessive levels of lead, which caused concern among parents. Subsequently, Fonterra responded by stating that a third-party retest on the same batch of products showed satisfactory results (lead content < 0.007mg/kg, below Macau’s standard of < 0.02mg/kg). Today, multiple Macau departments collaborated to expand the testing scope and tested a total of 13 samples from the 1st to 4th formulas of this brand, all of which had normal lead levels. The Health Bureau has established a pediatric emergency green channel, but there are no immediate cases of lead poisoning. Fonterra will also engage with Macau authorities to resolve any discrepancies in the testing results.
Detailed Explanation
1. The Turnaround of the Incident: From “Excessive Levels” to “Full Compliance”
On July 25th, Macau announced that Royal Nestle Milk Powder 1 had excessive lead levels, which alarmed many parents who were feeding their babies this formula. However, Fonterra quickly responded by having an independent third-party laboratory retest the same batch of products, and the results showed that the lead content was well below Macau’s standard (0.007mg/kg vs 0.02mg/kg), confirming that the product was safe. Today, additional actions were taken by Macau authorities to test all formulas from the 1st to 4th series (covering newborns to children over 3 years old), and all 13 samples passed the test. This development reassured parents that the initial issue might have been due to individual samples or a minor flaw in the testing process, rather than a broader problem with the entire brand.
2. Expanded Testing Scope: More Reliable Results
This time, Macau did not limit its testing to the previously affected batch but included all formulas from the Royal Nestle Milk Powder series (1-4th). With 13 samples tested in total, it was confirmed that the lead levels were within acceptable limits across all age groups. This confirms the safety of the entire product line, and parents do not need to worry about the brand based on the initial report, as long as they purchased the formula through official channels.
3. Impact on Children’s Health: No Urgent Cases, No Need for Excessive Anxiety
The Macau Health Bureau set up a pediatric emergency green channel to facilitate testing for lead poisoning. So far, no children have shown acute symptoms of lead poisoning, such as vomiting or lethargy. This indicates that even if some children consumed the affected batch, it did not immediately cause serious health issues. If parents are still concerned, they can take their children for a check-up, but there is no need to panic, as lead poisoning typically develops over time and short-term exposure is unlikely to cause immediate problems.
4. Follow-up Actions by the Company and Authorities: Fonterra to Resolve Disagreements
Fonterra needs to discuss the discrepancies in the testing results with Macau authorities. Possible reasons for these differences include different testing methods, variations in the samples collected, or differing interpretations of the “excessive lead” standard. The purpose of this discussion is to clarify the issues and prevent similar misunderstandings in the future, thereby enhancing consumer confidence in the product’s safety.
5. Regulatory Response: Multi-Disciplinary Cooperation Demonstrates Responsibility
Macau’s response involved multiple departments (such as the Health Bureau and Food Safety Department), which not only expanded the testing but also established a green channel for parents. This approach quickly addressed public concerns and ensured a thorough investigation of the issue, providing parents with clear answers. It demonstrates the government’s commitment to food safety and its effort to prevent minor issues from causing widespread panic.
In summary, although the initial report caused concern among parents, the subsequent testing results and measures taken are quite reassuring. If parents have any doubts, they should follow official updates or take their children for a check-up, but there is no need for excessive anxiety. The follow-up actions by both the company and regulatory authorities will help to prevent similar issues from occurring in the future.